Myo-Inositol Treatment Increases Serum Plasmalogens and Decreases Small Dense LDL, Particularly in Hyperlipidemic Subjects with Metabolic Syndrome-Reference-Cited by-同舟云学术

Myo-Inositol Treatment Increases Serum Plasmalogens and Decreases Small Dense LDL, Particularly in Hyperlipidemic Subjects with Metabolic Syndrome

Published:2008 Issue:3 Volume:54 Page:196-202
ISSN:0301-4800
Container-title:Journal of Nutritional Science and Vitaminology
language:en
Short-container-title:J Nutr Sci Vitaminol

Author:

MAEBA Ryouta,HARA Hiroshi,ISHIKAWA Hiroshi,HAYASHI Shigeru,YOSHIMURA Nakayuki,KUSANO Jyun,TAKEOKA Yoko,YASUDA Daijiro,OKAZAKI Tomoki,KINOSHITA Makoto,TERAMOTO Tamio

Publisher

Center for Academic Publications Japan

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Reference22 articles.

1. 1) Brosche T. 2001. Plasmalogen levels in serum from patients with impaired carbohydrate or lipid metabolism and in elderly subjects with normal metabolic values. Arch Gerontol Geriatr 32: 283-294.

2. Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolemia treated by LDL apheresis

3. Plasmalogens in Human Serum Positively Correlate with High- Density Lipoprotein and Decrease with Aging

4. 5) Pallauf J, Rimbach G. 1997. Nutritional significance of phytic acid and phytase. Arch Tierernahr 50: 301-319.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myo-inositol rescued insulin resistance and dyslipidemia in db/db mice;Journal of Applied Biomedicine;2024-06-24

2. Myo-inositol moderates maternal BMI and glycemia related variations in in-vitro placental 13C-DHA-metabolism, altering their relationships with birthweight;Scientific Reports;2022-09-01

3. Plasmalogen Replacement Therapy;Membranes;2021-10-29

4. Lipids: biomarkers of healthy aging;Biogerontology;2021-04-10

5. Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation;Nutrients;2020-11-03